# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001601830-22-000018
Filing Date
2022-04-28
Accepted
2022-04-28 16:03:45
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | rxrx_proxystatement2022-ad.htm | DEFA14A | 12277
2 |  | image_0a.jpg | GRAPHIC | 666061
3 |  | image_1a.jpg | GRAPHIC | 369750
| Complete submission text file | 0001601830-22-000018.txt |  | 1439605

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40323 | Film No.: 22866411
SIC: 2836 Biological Products, (No Diagnostic Substances)